Global Protein Labeling Market

1 INTRODUCTION OF GLOBAL PROTEIN LABELINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROTEIN LABELINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PROTEIN LABELING MARKET, BY LABELING METHOD:
5.1 In Vitro Labeling
5.1.1 Enzymatic Labeling
5.1.2 Dye-Based Labeling
5.1.3 Cotranslational Labeling
5.1.4 Site-Specific Labeling
5.1.5 Nanoparticle Labeling
5.2 In Vivo Labeling
5.2.1 Photoreactive Labeling
5.2.2 Radioactive Labeling
5.3 Bio orthogonal Labeling

6 GLOBAL PROTEIN LABELING MARKET, BY APPLICATION:
6.1 Immunological Techniques
6.2 Cell-Based Assays
6.3 Fluorescence Microscopy
6.4 Protein Microarrays
6.5 Mass Spectrometry

7 GLOBAL PROTEIN LABELING MARKET, BY PRODUCT:
7.1 Reagents
7.1.1 Enzymes
7.1.2 Monoclonal Antibodies
7.1.3 Proteins
7.1.4 Probes/Tags
7.1.5 Other Reagents
7.2 Kits
7.3 Services

8 GLOBAL PROTEIN LABELINGMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL PROTEIN LABELINGMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Merck KGaA (Germany)
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Perkinelmer, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 F. Hoffman-La Roche AG
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 General Electric Company
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Kaneka Corporation
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Li-Cor, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 New England Biolabs
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Promega Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Seracare Life Sciences, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports